Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Kobayashi Pharmaceutical Revenue

Kobayashi Pharmaceutical had revenue of 43.02B JPY in the quarter ending September 30, 2025, with 4.11% growth. This brings the company's revenue in the last twelve months to 163.18B, down -3.33% year-over-year. In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B, down -4.53%.

• Revenue (ttm): 163.18B JPY
• Revenue Growth: -3.33%
• P/S Ratio: 2.29
• Revenue / Employee: 45.14M JPY
• Employees: 3,615
• Market Cap: 2.15B EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	165.60B	-7.86B	-4.53%
Dec 31, 2023	173.46B	7.20B	4.33%
Dec 31, 2022	166.26B	11.01B	7.09%
Dec 31, 2021	155.25B	4.74B	3.15%
Dec 31, 2020	150.51B	-17.54B	-10.44%